1. Home
  2. AMPH vs WYFI Comparison

AMPH vs WYFI Comparison

Compare AMPH & WYFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • WYFI
  • Stock Information
  • Founded
  • AMPH 1996
  • WYFI 2023
  • Country
  • AMPH United States
  • WYFI United States
  • Employees
  • AMPH N/A
  • WYFI N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • WYFI Finance: Consumer Services
  • Sector
  • AMPH Health Care
  • WYFI Finance
  • Exchange
  • AMPH Nasdaq
  • WYFI Nasdaq
  • Market Cap
  • AMPH 1.2B
  • WYFI 1.2B
  • IPO Year
  • AMPH 2014
  • WYFI 2025
  • Fundamental
  • Price
  • AMPH $24.39
  • WYFI $34.54
  • Analyst Decision
  • AMPH Buy
  • WYFI Strong Buy
  • Analyst Count
  • AMPH 6
  • WYFI 6
  • Target Price
  • AMPH $35.50
  • WYFI $31.17
  • AVG Volume (30 Days)
  • AMPH 369.0K
  • WYFI 1.4M
  • Earning Date
  • AMPH 11-06-2025
  • WYFI 12-09-2025
  • Dividend Yield
  • AMPH N/A
  • WYFI N/A
  • EPS Growth
  • AMPH N/A
  • WYFI N/A
  • EPS
  • AMPH 2.68
  • WYFI N/A
  • Revenue
  • AMPH $722,679,000.00
  • WYFI $62,303,715.00
  • Revenue This Year
  • AMPH $1.00
  • WYFI $84.38
  • Revenue Next Year
  • AMPH $6.74
  • WYFI $129.28
  • P/E Ratio
  • AMPH $9.15
  • WYFI N/A
  • Revenue Growth
  • AMPH 1.37
  • WYFI N/A
  • 52 Week Low
  • AMPH $20.39
  • WYFI $14.01
  • 52 Week High
  • AMPH $53.96
  • WYFI $40.75
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 40.87
  • WYFI N/A
  • Support Level
  • AMPH $22.94
  • WYFI N/A
  • Resistance Level
  • AMPH $24.87
  • WYFI N/A
  • Average True Range (ATR)
  • AMPH 0.79
  • WYFI 0.00
  • MACD
  • AMPH 0.12
  • WYFI 0.00
  • Stochastic Oscillator
  • AMPH 42.90
  • WYFI 0.00

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About WYFI WhiteFiber Inc. Ordinary Shares

Whitefiber Inc is a provider of artificial intelligence infrastructure solutions. The company owns high-performance computing data centers and provide cloud-based HPC graphics processing units services, which it terms cloud services, for customers such as AI application and machine learning developers. Its Tier-3 data centers provide hosting and colocation services. Its cloud services support generative AI workstreams, especially training and inference. It has two reportable segments: cloud services and colocation services. The cloud services segment generates revenue from providing high performance computing services to support generative AI workstreams. Colocation services generate revenue by providing customers with physical space, power and cooling within the data center facility.

Share on Social Networks: